The University of Chicago Header Logo

Connection

Anjana Pillai to Graft vs Host Disease

Back to Details
This is a "connection" page, showing publications Anjana Pillai has written about Graft vs Host Disease.
Anjana Pillai
Connection Strength
0.116
Graft vs Host Disease
  1. Simeprevir and Sofosbuvir (SMV-SOF) for 12 Weeks for the Treatment of Chronic Hepatitis C Genotype 1 Infection: A Real World (Transplant) Hepatology Practice Experience. Am J Gastroenterol. 2016 Feb; 111(2):250-60.
    View in: PubMed
    Score: 0.116
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.